Showing results (121-130 of 301) with videos related to
Sort By:
Pageof 31
Nuclear Medicine and Biology|June 29, 2005
Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugatesSerengulam V Govindan, Rosana B Michel, Gary L Griffiths, et al.Leukemia & Lymphoma|December 8, 2010
Evaluation of anti-human leukocyte antigen-DR monoclonal antibody therapy in spontaneous canine lymphomaRhona Stein, Cheryl Balkman, Susan Chen, et al.Theranostics|June 28, 2012
Pretargeted molecular imaging and radioimmunotherapyDavid M Goldenberg, Chien-Hsing Chang, Edmund A Rossi, et al.Molecular Cancer|March 11, 2014
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancerDonglin Liu, Thomas M Cardillo, Yang Wang, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2005
A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancerRobert M Sharkey, George Hajjar, Dion Yeldell, et al.Cancer Research|October 17, 2008
Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeuticsEdmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.Cancer|February 4, 2010
Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancerFrançoise Kraeber-Bodéré, Pierre-Yves Salaun, Aurore Oudoux, et al.Leukemia & Lymphoma|August 1, 2002
Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents: a new generation of therapeuticsMiriam Hursey, Dianne L Newton, Hans J Hansen, et al.Blood|November 21, 2007
Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of actionZhengxing Qu, David M Goldenberg, Thomas M Cardillo, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 2, 2014
SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibodyMark Rijpkema, Wim J Oyen, Desiree Bos, et al.Pageof 31